ABOUT THIS PODCAST 🔗

Update frequency:
monthly
Average audio length:
21 minutes
Guest interviews
Has sponsors
English
United States
12 episodes
since April 11, 2025
episodic

LATEST EPISODE 🔗

In this special Crimes Against Innovation episode, host Nicola Hill hears two charges against pharma. Erik Janssen, UCB’s Vice President and Head of Digital Care Transformation, argues that ‘pilotitis’ is 'the most expensive way to look innovative’, with organizations trapped in pilots that generat…

SEARCH PAST EPISODES

Search past episodes of Hypothesize That!.

PREVIOUS EPISODES

AI can already diagnose some conditions faster than humans. Robots are entering hospitals. So, are we heading towards a future without doctors? Nicola Hill sits down with UCB's Vice President and Head of Digital Care Transformation, Erik Janssen and healthcare innovation expert Gary Monk to debate …
In this special Crimes Against Innovation episode, host Nicola Hill hears two charges against the research system.   Professor Raj Chovatiya argues that the academic model is putting the brakes on innovation, squeezing creativity and collaboration. Meanwhile, Dr Joe Rastrick condemns the irre…
In this episode, we ask a defining question: will multi-specific therapies revolutionize how we treat complex diseases? Host Nicola Hill is joined by Dr Joe Rastrick (UCB) and Professor Raj Chovatiya (Rosalind Franklin University) to examine whether medicines engineered to target multiple pathways …
Deep in the shadowy corridors of laboratories and the silent pages of medical journals, progress can falter, not for lack of brilliance, but because of the systems surrounding it. Ideas are delayed, discoveries are hidden, and bold thinking is quietly discouraged. This is Crimes Against Innovation.…
Are today’s clinical trials fit for the future of medicine, or are they holding innovation back?   In this episode, host Nicola Hill, is joined by Professor Maddie Parsons, Dean of Research Excellence Frameworks at King’s College London, and Dr Graham Price, Head of Global Clinical Developme…
In the darkened corridors of laboratories and the silent pages of medical journals, there are stories rarely spoken about—tales of brilliance that burned too bright, and ideas that strayed into catastrophe. This is—Crimes Against Innovation.   Laurence Woollard and Dr. Emma Lane debate two pre…
Is scientific innovation enough to drive the future of gene therapy, or is patient engagement the missing key? Join host Nicola Hill as she explores this question with Laurence Woollard, a rare disease advocate, and UCB’s Global Patient Engagement Lead, Dr. Emma Lane. Together, they discuss the cri…
In the shadowy corridors of laboratories and the silent pages of medical journals, there lie tales that have seldom been told. Tales of ambition that flew too close to the sun, of genius that turned into folly, and of innovation that... well, wasn't quite so innovative. This is—Crimes Against Innov…
Could the clinical trials of the future operate seamlessly in the background of our daily lives? In this episode, host Nicola Hill explores the hypothesis that fully virtualised decentralized clinical trials (DCT), that operate invisibly, will make traditional models obsolete within the next decade…
Disclaimer: The podcast and artwork embedded on this page are from UCB Biopharma, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.